Differences in Dry Eye Symptoms Related to Geographic Location in Spain and Impact of Artificial Tears Use
NCT06499753 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1033
Last updated 2024-07-17
Summary
This study assessed the differences in DED symptomatology measured with the OSDI questionnaire regarding climate data of the geographic location in a large population in Spain, with a special focus on the relative humidity (RH) of the place of residence and the impact of artificial tears use, to help eye care practitioners in patient management and education
Conditions
- Dry Eye Syndromes
- Hyaluronic Acid
- OSDI
Interventions
- OTHER
-
high molecular weight HA-based artificial tears
use of high molecular weight HA-based artificial tears three times per day
Sponsors & Collaborators
-
University of Valladolid
lead OTHER
Principal Investigators
-
Raul Martin, PhD · IOBA Eye Institute
Eligibility
- Min Age
- 18 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-02-01
- Primary Completion
- 2020-11-30
- Completion
- 2022-01-31
Countries
- Spain
Study Locations
More Related Trials
-
Tear Dynamics After Restasis Treatment in Dry Eye Patients
NCT00706940 ·Status: COMPLETED
-
Effect of Artificial Tears on Ocular Biometry Parameters
NCT06656403 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Effects of NOV03 on the Tear Film
NCT05723770 ·Status: COMPLETED ·Phase: PHASE4
-
Latanoprost Preserved Versus Unpreserved: Effect on Tear Film Thickness as Measured With OCT
NCT02585375 ·Status: UNKNOWN ·Phase: PHASE4
-
PMCF Study to Evaluate Performance and Safety of "CLHA-based Eyedrops" Used to Improve Lacrimal Abnormalities
NCT05823961 ·Status: COMPLETED ·Phase: NA
-
A Natural History Study of Patients With Dry Eye
NCT00833235 ·Status: COMPLETED
-
The Effects and Safety of Topical Spironolactone Ophthalmic Solution, 0.005 mg/cc in Subjects With Dry Eye Disease
NCT05995392 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Investigation of Preservative-Free Ophthalmic Solution in Ocular Dryness
NCT05778942 ·Status: COMPLETED
-
Cross-linked Hyaluronic Acid and Coenzyme Q10 in the Treatment of Dry Eye
NCT03074344 ·Status: COMPLETED ·Phase: NA
-
Post-marketing Study Focused on Evaluating I+Med's DayDrop for Improving Signs and Symptoms of Mild/Moderate Dry Eye
NCT06731725 ·Status: COMPLETED ·Phase: NA
-
Study of SY-201 Ophthalmic Solution in Subjects With Dry Eye Disease
NCT05370495 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study on Safety and Performance of an Artificial Tear in Dry Eye Treatment in Subjects With Ocular Surface Inflammation
NCT04633863 ·Status: COMPLETED ·Phase: NA
-
Assessing the Safety and Efficacy of AVX-012 in Subjects With Mild-to-moderate Dry Eye Syndrome
NCT03162094 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Influence of Three Different Formulations of Lachrymal Substitutes on Tear Film Thickness and Other Signs and Symptoms in Patients With Moderate to Severe Dry Eye Syndrome
NCT02986750 ·Status: COMPLETED ·Phase: PHASE4
-
A Study Assessing the Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients
NCT01468168 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess Efficacy and Safety of HL036 in Subjects With Dry Eyes
NCT03846453 ·Status: COMPLETED ·Phase: PHASE3
-
Crosslinked Hyaluronic Acid With Liposomes and Crocin in Dry Eye
NCT03617315 ·Status: COMPLETED ·Phase: NA
-
Study to Compare the Efficacy and Safety of Two Non-Preserved Artificial Tears for the Treatment of Dry Eye Signs and Symptoms
NCT00938704 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Olixia Pure® Eye Drops on Tear Film Thickness in Healthy Subjects
NCT01970917 ·Status: COMPLETED ·Phase: PHASE4
-
Comprehensive Study on Dry Eye and Ocular Surface Disease Prior and After Cataract Surgery
NCT04711642 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy and Safety of the Ophthalmic Solution PRO-087 Versus Systane ® Ultra and Ultra Preservative Free (087LATAMFIV)
NCT03223909 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Povidone-iodine 5% Vs 1% on the Ocular Surface in Intravitreal Injections of Anti-VEGF
NCT06710951 ·Status: COMPLETED ·Phase: NA
-
A Study Assessing the Safety, Efficacy, and Optimum Dosage of K-161 in Subjects With Moderate to Severe Dry Eye Disease
NCT04084483 ·Status: COMPLETED ·Phase: PHASE2
-
Diurnal Variation in Tear Osmolarity
NCT01321424 ·Status: COMPLETED
-
A Post-market Study to Evaluate the Effects of Sodium Hyaluronate Based Eye Drops in Patients Affected by Dry Eye Disease
NCT05773963 ·Status: TERMINATED ·Phase: NA